What do the labels say about a missed semaglutide dose?
| Label | Missed weekly dose |
|---|---|
| Ozempic, US | Given as soon as possible within 5 days, skipped after that1 |
| Ozempic, Europe | Within 5 days, skipped after that4 |
| Wegovy, US | Taken if the next dose is more than 2 days (48 hours) away, skipped if less2 |
| Wegovy, Europe | Within 5 days, skipped after that3 |
| Zepbound, US | Within 4 days (96 hours), skipped after that5 |
| Mounjaro, US | Within 4 days (96 hours), skipped after that6 |
| Mounjaro, Europe | Taken if 4 days or less since it was due, skipped if more7 |
How late a weekly dose can be taken
The same molecule carries a 2-day rule on the US Wegovy label, counted to the next scheduled dose, and a 5-day rule on the US Ozempic label and the European Wegovy and Ozempic texts, counted from the missed dose.2134
The table is set at the top of the page
The tirzepatide labels give 4 days where the Ozempic labels give 5.56714
The European Wegovy and Ozempic leaflets say not to use a double dose to make up for a forgotten one.34 The Zepbound and Mounjaro US texts say not to take 2 doses within 3 days of each other, and the European Mounjaro text sets the minimum time between two doses at 3 days.567
Several missed weeks
The US Wegovy label says that after 2 or more consecutive missed injections, dose escalation is restarted at a lower dosage to reduce the risk of gastrointestinal adverse reactions.2 Its patient instructions tell people who miss 2 or more consecutive weeks to contact their healthcare provider about restarting.2 The European Wegovy text says a reduced starting dose for re-initiation is to be considered if more doses are missed, and gives no number of doses.3 The Zepbound and Mounjaro US labels, the European Mounjaro text and both Ozempic labels give no rule for several missed doses.
Side effects and dose escalation
The European Wegovy text lists gastrointestinal disorders including nausea as the most frequently reported adverse reactions.3 The US Wegovy label says to follow its dose escalation schedule to reduce the risk of gastrointestinal adverse reactions.2 Reactions by missed-dose status are not reported in any label or trial found; the US Wegovy label's gastrointestinal figures cover the whole trial population.
Frequently asked questions
Can the injection day be changed after a missed dose?
The US Ozempic and Wegovy labels allow a change of weekly day when the two doses are at least 2 days apart.12 The US Zepbound label sets that gap at 3 days.5 The US Mounjaro label also sets it at 3 days (72 hours), and the European Wegovy, Ozempic and Mounjaro texts set it at 3 days, given as more than 72 hours in the Wegovy and Ozempic texts.6347
Why does the half-life matter for a late dose?
The US Ozempic label gives semaglutide a half-life of approximately 1 week, with the drug present in the circulation for about 5 weeks after the last dose.1 The US Zepbound label gives tirzepatide an elimination half-life of approximately 5-6 days in people with overweight or obesity.5 The US Mounjaro label gives tirzepatide an elimination half-life of approximately 5 days.6
What about CJC-1295 and testosterone missed doses?
DailyMed lists no label for CJC-1295, so no missed-dose rule is given for it. The Depo-Testosterone and Xyosted labels contain no missed-dose, skipped-dose or forgotten-dose instruction.
- Tirzepatide dosageLabel doses and schedules for tirzepatide.
- TRT injection frequencyHow testosterone schedules are set up.
- SemaglutideThe compound page.
- GLP-1 trackerLog weekly doses.
- Units and dosingHow doses and syringe units relate.
- Eight reasons peptides show no resultsTiming and consistency among them.
References
- Novo Nordisk (DailyMed). OZEMPIC (semaglutide) injection, US prescribing information. 2026. dailymed.nlm.nih.gov
- Novo Nordisk (DailyMed). WEGOVY (semaglutide) injection and tablets, US prescribing information. 2026. dailymed.nlm.nih.gov
- European Medicines Agency. Wegovy, European product information (summary of product characteristics and package leaflet). ema.europa.eu
- European Medicines Agency. Ozempic, European product information (summary of product characteristics and package leaflet). ema.europa.eu
- Eli Lilly (DailyMed). ZEPBOUND (tirzepatide) injection, US prescribing information. 2026. dailymed.nlm.nih.gov
- Eli Lilly (DailyMed). MOUNJARO (tirzepatide) injection, US prescribing information. 2026. dailymed.nlm.nih.gov
- European Medicines Agency. Mounjaro, European product information (summary of product characteristics and package leaflet). ema.europa.eu
- Novo Nordisk (DailyMed). RYBELSUS and OZEMPIC tablets (oral semaglutide), US prescribing information. 2026. dailymed.nlm.nih.gov